Marsh (MRSH) Q3 2026 (USD): Adj. EPS 2.03 (exp. 1.97), Revenue 6.90bln (exp. 6.65bln)

A beat on both lines of this modest size sits within the normal range for a large insurance broker, a sector where results are typically steady rather than explosive because revenue is driven by recurring commission and fee streams rather than transactional volume. For brokers, the line that has historically moved the stock more than headline EPS is organic revenue growth, since it strips out acquisitions and FX and reveals the underlying demand trend; the composition between the risk and insurance services arm and the consulting arm also matters, as the two respond to different cycles, with placement results tracking commercial premium pricing while consulting tracks employment and benefits spending. Another established swing factor in this sector has been fiduciary interest income on client funds, which has flattered earnings across the peer set in higher-rate periods and faded as rates fall, so the split between operating performance and interest tailwind is the usual first question. Prior form in this peer group is that modest double beats with in-line guidance produce limited follow-through, while any signal on premium pricing direction, retention rates, or M&A pipeline in the commentary carries more weight than the print itself. The immediate follow-ons are the call tone on organic growth and margin, and read-across to the other large brokers reporting in the same window.